Frequently Asked Questions
With the COVID-19 pandemic, lockdowns, and stringent regulations, the global economy and various industry verticals, including healthcare, were greatly impacted. Health care, radiology practices, and academic radiology departments experienced financial consequences.
North America accounted for the most heightened share in the global breast biopsy devices market.
Market growth is estimated to be driven by an increase in breast cancers in women worldwide and cancer awareness screening programs.
The biopsy needles segment had a major share in the global market in 2022.
The hospital segment had a major share in the global market.